Mauro Loi, MD

Azienda Ospedaliera Universitaria Careggi
Florence, Tuscany

Disclosures:

Presentations

Sep 30

1076 - Early Results from a Randomized Phase II Trial Testing Apalutamide and Stereotactic Body Radiation Therapy for Low-Burden Mhspc (NCT05717660)
04:25pm - 04:30pm PT
Sep 28

2161 - Artificial Intelligence-Based Assessment of Combined Dosiomic and Radiomic Features for Prediction of Metastatic Recurrence in Soft Tissue Sarcoma Treated with Preoperative Radiotherapy
Hall F
02:30pm - 04:00pm PT
Sep 30

3484 - Surgical Outcomes In Locally Advanced Rectal Cancer Following Preoperative Chemoradiation With Simultaneous Integrated Boost (SIB-CRT)
Hall F
02:30pm - 03:45pm PT
Sep 29

3098 - The Orphan Gene CCDC97 is Involved in DNA Damage Response and Ferroptosis Modulation
Hall F
05:00pm - 06:00pm PT
Sep 30

3483 - KRAS Mutations as Predictor of Radioresistance in Pulmonary Metastases from Colorectal Cancer
Hall F
02:30pm - 03:45pm PT